Abstract:The development of the pharmaceutical industry is the cornerstone for safeguarding people’s lives and health. This study is based on a macro perspective and provides a comprehensive and in-depth comparison of the development trend of the pharmaceutical industry in China and abroad. It is pointed out that the global market size and strategic position of the pharmaceutical industry in various countries are constantly improving. Meanwhile, the development prospect of China’s pharmaceutical industry is broad, and the potential market space is large. On this basis, we further explore the development prospects and driving factors of China’s pharmaceutical industry, including changes in population structure and increased health awareness, increasing global competitive pressure, sustained government investment and support for the pharmaceutical industry, and increase in research and development (R & D) investment by leading enterprises. Moreover, from the perspective of medical practice, we propose the challenges faced by the pharmaceutical industry in five aspects: precision, safety, timeliness, affordability, and policy guarantee. Furthermore, in response to the challenges we face, we propose the following targeted countermeasures: (1) building and maintaining a refined large-populationbased cohort and data platform while providing sustained support; (2) accelerating the R & D and transformation of China’s internationally leading technologies in the pharmaceutical industry to strengthen original innovation and seize the market; (3) promoting the industrialization of pharmaceutical R & D by encouraging industry–education–research integration in the R & D and clinical trials stage, strengthening the evaluation ability in the evaluation stage, and improving guarantee services such as intellectual property protection in the promotion stage of innovative products; (4) improving multi-level medical security channels to strive for more sources of support and reduce the burden of self-payment for patients; and (5) enhancing the full chain of policy protection and implementation efficiency to effectively stimulate the development momentum of the medical industry. This study aims to provide a reference for the subsequent investment, policy formulation, and development decisions of China’s pharmaceutical industry.

Comparative Study on Pharmaceutical Data Protection System of China and Japan

Discussion on Legal Basis of Drug Data Protection System

Impact of medical data protection on drug expenditure and accessibility in China

Policy selection of regulatory data protection under the background of drug innovation strategy in China

Health Technology Assessment and Its Use in Drug Policies in China

A Legal Analysis on the Current Trade Status of Traditional Chinese Medicinal Product in the E.U. — From the Perspectives of WTO Law and E.U. Pharmaceutical Law

Introduction and Profound Consideration on Intellectual Property Rights Protection Standard Terms Relat-ed to Drugs beyond the Regulations of TRIPS

TRIPS-plus and Access to Medicines in China.

Rethinking Test Data Protection in China-US Trade War: Integrating Empirical and Normative Analysis

Comparison and Analysis of the Health Products Supervisions in China,Japan,USA and EU

Analysis of Protecting for Chinese Medical and Pharmaceutical Intellectual Property

Analysis of the Protection to Marketing Approval Data under the TRIPS Agreement

Analysis and Comparison of Foreign and Domestic Orphan Drug Registration Policies

Experience and Enlightenment of Drug Price Regulation in Germany,Japan and Taiwan Area of China

Research on the Protection Strategy of the Traditional Chinese Medicine Intellectual Property

International Trade Barriers and Countermeasures of Chinese Medicinal Materials Based on Big Data

Analysis on Situation of Traditional Chinese Medicine Development and Protection Strategies in China

Pharmaceutical corporate power, traditional medical knowledge, and intellectual property governance in China

Recent Advances in Drug Development and Regulatory Science in China

Analysis and Prospect of the Pharmaceutical Industry Development Trend in China

Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems